Third autologous stem cell transplants for late relapse of multiple myeloma

Bone Marrow Transplantation

Volumn 17, Issue 5, 1996, Pages 885-886

  Jourdan, E ^a   Biaise, D ^b   Fegueux, N ^a   Navarro, R ^a   Rossi, J F ^a   Maraninchi, D ^b   Navarro, M ^a  

^a LAPEYRONIE HOSPITAL   (France)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

Autologous stem cell transplantation; Multiple myeloma; Relapse

Indexed keywords

BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; IFOSFAMIDE; IMMUNOGLOBULIN LAMBDA CHAIN; MELPHALAN; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; CASE REPORT; HUMAN; HUMAN CELL; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; RELAPSE; REMISSION; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RECURRENCE; RETREATMENT; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029948942     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. McElwain T, Powles R. High dose intravenous melphalan for plasma cell leukemia and myeloma. Lancer 1983; 2: 822-823.
2. Selby P, McElwain T, Nandi A et al. Multiple myeloma treated with high dose intravenous melphalan. Br J Haematol 1987; 66: 55-62.
3. Barlogie B, Hall R, Zander A et al. High dose meiphalan with autologous bone marrow transplantation for multiple myeloma. Blood 1986; 67: 1298-1301.
4. Barlogie B, Alexanian R, Dicke K et al. High dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood 1987; 70: 869-872.
5. Fermant J, Levy, Y, Gerota J et al. Treatment of aggressive multiple myeloma by high dose chemotherapy and total body irradiation followed by blood stem cells autologous graft. Blood 1989; 73: 20-23.
6. Reiffers J, Marit G, Boiron J. Autologous blood stem cell transplantation in high risk multiple myeloma. Br J Haematol 1989; 72: 296-297.
7. Attal M, Harousseau J, Stoppa A et al. High dose therapy in multiple myeloma: a prospective randomized study of the 'Intergroupe Français du Myélome' (IFM). Blood 1994; 84 (Suppl. I): 386a.
8. Harousseau J, Milpied N, Laporte J et al. Double intensive therapy in high risk multiple myeloma. Blood 1992; 79: 2827-2833.
9. Vesole D, Barlogie B, Jagannath S et al. High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants. Blood 1994; 84: 950-956.
10. Colombat P, Milpied N, Laporte J et al. Three courses of high dose therapy. Feasibility in the treatment of multiple myeloma - a 'France autogreffe' study. Cancer 1994; 74: 2930-2934.
11. Tricot G, Jagannath S, Vesole D et al. Relapse of multiple myeloma after autologous transplantation: survival after salvage therapy. Bone Marrow Transplant 1995; 16: 7-11.